ASMB
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Assembly Biosciences reports positive Phase 1b results for ABI-1179 and ABI-5366 showing reduced viral shedding in recurrent genital herpesDec 9, 2025
- Assembly Biosciences presents interim Phase 1b data for HSV helicase-primase inhibitor candidate ABI-5366 at 38th Congress of International Union Against Sexually Transmitted Infections (IUSTI) - EuropeOct 10, 2025
- Assembly Biosciences reports positive interim results from Phase 1b clinical study of long-acting helicase-primase inhibitor ABI-5366 showing reduced viral shedding and genital lesion rates in recurrent genital herpesAug 8, 2025
- Assembly Biosciences reports interim Phase 1a data from clinical study of oral entry inhibitor candidate ABI-6250 for hepatitis delta virusAug 7, 2025
- Assembly Biosciences doses first participant in Phase 1b of clinical trial for long-acting HSV helicase-primase inhibitor ABI-1179Jun 30, 2025